Safety and Efficacy of Ranolazine for the Treatment of Amyotrophic Lateral Sclerosis
Clinical trial NCT03472950 · COMPLETED
Trial details
- NCT number
- NCT03472950
- Sponsor
- University of Kansas Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-11
- Primary completion
- 2020-12-11
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.